Technical Analysis for NUVO - Holdco Nuvo Group D.G Ltd.

Grade Last Price % Change Price Change
F 1.80 3.45% 0.06
NUVO closed up 3.45 percent on Friday, May 17, 2024, on 20 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 3.45%
Narrow Range Bar Range Contraction 3.45%
New 52 Week Low Weakness 3.45%
Wide Bands Range Expansion 3.45%
Down 3 Days in a Row Weakness 3.45%

   Recent Intraday Alerts

Alert Time
Possible NR7 1 day ago
Possible Inside Day 1 day ago
Up 5% 1 day ago
Up 3% 1 day ago
Up 2% 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Holdco Nuvo Group D.G Ltd. Description

Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo's INVU™ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring, while pioneering new data-driven personalized pathways that Nuvo believes can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo plans to continue to expand the footprint of sales in the US and Israel and plans to introduce its INVU platform in Europe in 2024, subject to granting of the CE mark it filed in Europe in March 2023, to provide remote access and insights not previously deemed possible. Nuvo is led by a diverse team of experienced business, medical and technology leaders, united in the mission of breaking down barriers to pregnancy care to give every life a better beginning.


Classification

Sector: Financial Services
Industry: Shell Companies
Keywords: FDA Obstetrics Childbirth Women's Health Midwifery Pregnancy Prenatal Testing

Is NUVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.5
52 Week Low 1.73
Average Volume 1,049,727
200-Day Moving Average 9.93
50-Day Moving Average 7.61
20-Day Moving Average 4.44
10-Day Moving Average 2.62
Average True Range 1.33
RSI (14) 33.33
ADX 18.65
+DI 17.67
-DI 23.25
Chandelier Exit (Long, 3 ATRs) 4.56
Chandelier Exit (Short, 3 ATRs) 5.73
Upper Bollinger Bands 8.96
Lower Bollinger Band -0.08
Percent B (%b) 0.21
BandWidth 203.60
MACD Line -1.73
MACD Signal Line -1.60
MACD Histogram -0.1315
Fundamentals Value
Market Cap 22.49 Million
Num Shares 12.5 Million
EPS -0.10
Price-to-Earnings (P/E) Ratio -18.00
Price-to-Sales 1000000.00
Price-to-Book 9.99
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.03
Resistance 3 (R3) 2.03 1.97 1.99
Resistance 2 (R2) 1.97 1.91 1.96 1.97
Resistance 1 (R1) 1.88 1.87 1.93 1.88 1.96
Pivot Point 1.82 1.82 1.84 1.81 1.82
Support 1 (S1) 1.73 1.76 1.78 1.73 1.64
Support 2 (S2) 1.67 1.72 1.66 1.63
Support 3 (S3) 1.58 1.67 1.61
Support 4 (S4) 1.58